FluMist may be used in $2.5 billion federal program FDA approves new form of Lamisil BioSante completes FDA required studies of LibiGel Kerr Drug launches statewide Flugram influenza vaccination program Ranbaxy to form separate R&D company Mylan enters into agreement with UCB over Keppra litigation Pfizer hires two scientists to boost research operations IRI launches Shopper Insights Explorer Merck wins Florida liability suit Teva releases generic Coreg First Previous 2674 2675 2676 2677 2678 Next Last
